SLC29A1 and pachyonychia congenita: No matter which antibody is used, S‐1 is the first choice of adjuvant chemotherapy for the PC patients with low hENT1 expression, whereas either S‐1 or GEM can be introduced for the PC patients with high hENT1 expression.